| 102039-76-9 |
|
3-deoxy-3-fluorosucrose |
C12H21FO10 |
344.2900 |
-
|
| 102039-79-2 |
2-乙酰氨基-2-脱氧-Β-D-吡喃半乳糖胺 |
2-Acetamido-2-Deoxy-Β-D-Galactopyranosylamine |
C8H16N2O5 |
220.2200 |
-
|
| 102039-86-1 |
|
Cephaloridine Monohydrate |
C19H19N3O5S2 |
433.5000 |
-
|
| 102039-88-3 |
|
Pyridinium, 4-propyl-, dicyanomethylide |
C11H11N3 |
- |
-
|
| 1020396-26-2 |
(R)-3-氨基-1-乙基哌啶 |
(3R)Ethylpiperidin-(R)-3-Amino-1-Ethylpiperidine |
C7H16N2 |
128.2200 |
-
|
| 1020399-49-8 |
CARM1抑制剂 |
Prmt4/Carm1 Inhibitor |
C26H21Br2NO3 |
555.2600 |
-
|
| 1020399-52-3 |
表观遗传多重配体 |
Epigeneticmultipleligand |
C19H12Br4O4 |
623.9100 |
-
|
| 10204-14-5 |
|
4(3H)-Quinazolinone, 2-(4-methyl-1-piperazinyl)-3-phenyl- |
C19H20N4O |
- |
-
|
| 10204-66-7 |
|
(3beta,5beta,14beta,17beta)-3-(acetyloxy)-14-hydroxyandrostane-17-carboxylic acid |
C22H34O5 |
378.5000 |
-
|
| 102040-01-7 |
|
carbendazim |
C9H9N3O2 |
191.1900 |
-
|
| 102040-03-9 |
土贝母皂苷甲 |
Hydroxy-3-Methyl-1-Oxobutyl)-Α-L-Arabinopyra |
C63H98O29 |
1319.4300 |
-
|
| 102040-04-0 |
|
Naphtho[2,3-c]furan-1(3H)-one,9-(3,4-dihydroxyphenyl)-4-hydroxy-6,7-dimethoxy- |
C20H16O7 |
- |
-
|
| 102040-08-4 |
|
sodium (22E)-3,4,8,15-tetrahydroxy-26-{[2-O-(2-O-methylpentopyranosyl)pentopyranosyl]oxy}ergost-22-en-6-yl sulfate |
C39H65NaO17S |
860.9800 |
-
|
| 102040-09-5 |
|
Cholestane-3,4,6,8,15,16-hexol,24-[[2-O-(2,4-di-O-methyl-b-D-xylopyranosyl)-a-L-arabinofuranosyl]oxy]-, (3b,4b,5a,6a,15b,16b,24S)- (9CI) |
C39H68O15 |
- |
-
|
| 102040-10-8 |
|
Cholestane-3,6,8,15-tetrol,24-[[2-O-(2,4-di-O-methyl-b-D-xylopyranosyl)-a-L-arabinofuranosyl]oxy]-, (3b,5a,6a,15b,24S)- |
C39H68O13 |
- |
-
|
| 102040-34-6 |
|
2-Propenoic acid, 2-methyl-, (2-oxo-3(2H)-benzothiazolyl)methyl ester |
C12H11NO3S |
- |
-
|
| 102040-42-6 |
|
Benzenamine, 2-nitro-4-octyl- |
C14H22N2O2 |
- |
-
|
| 102040-43-7 |
|
Acetamide, N-(2-nitro-4-octylphenyl)- |
C16H24N2O3 |
- |
-
|
| 102040-91-5 |
|
Pentanoic acid, 5-amino-5-oxo-, methyl ester |
C6H11NO3 |
- |
-
|
| 102040-94-8 |
|
2-Butenamide, N-(bromoacetyl)-, (2E)- |
C6H8BrNO2 |
- |
-
|